In the current study, we provided some lines of evidence in the first time revealing that the activity of a cytosolic protein tyrosine phosphatase, i.e., SHP2, was enhanced in kidney biopsies of DN patients as well as db/db mice. This evidence concerns the gene PTPN11 and liver dysplastic nodule.